Thursday, November 30, 2023
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Professor
HIV/AIDS Unit Director,
Division of Infectious Diseases
Geneva University Hospitals
Geneva, Switzerland
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This activity is intended for physicians, nurses, nurse practitioners (NPs), physician assistants (PAs) involved in the care of high-risk patients with mild to moderate COVID-19 disease who are interested in setting up an infusion center for monoclonal antibodies (mAbs).
The goal of this activity is to provide physicians and healthcare practitioners (HCPs) with expert guidance on best practices based on the latest clinical and real-world use of mAb infusions, and to foster their appropriate use in the treatment of patients with mild to moderate COVID-19.
Upon completion of this activity, participants will:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Professor
HIV/AIDS Unit Director,
Division of Infectious Diseases
Geneva University Hospitals
Geneva, Switzerland
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.5 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 1/3/2022
Valid for credit through: 1/3/2023, 11:59 PM EST
processing....
The goal of this activity is to provide physicians and healthcare practitioners (HCPs) with expert guidance on best practices based on the latest clinical and real-world use of mAb infusions, and to foster their appropriate use in the treatment of patients with mild to moderate COVID-19.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
